{
    "clinical_study": {
        "@rank": "52140", 
        "arm_group": [
            {
                "arm_group_label": "Pyruvic acid", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive pyruvic acid solution 70% prepared by solving of pyruvic acid in water/ethanol solution. Patients will be advised to apply the solution twice daily for a period of four weeks. Application of petrolatum to the surrounding normal skin protects against the corrosive effect of the concentrated acid."
            }, 
            {
                "arm_group_label": "Salicylic acid", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive a combination of salicylic acid 16.7%, lactic acid 16.7%, and collodion 100%. Patients will be advised to apply the solution twice daily for a period of four weeks. Application of petrolatum to the surrounding normal skin protects against the corrosive effect of the concentrated acid."
            }
        ], 
        "brief_summary": {
            "textblock": "Plantar warts can be bothersome and painful requiring treatment. The investigators will\n      compare the efficacy of pyruvic acid and salicylic acid in treating multiple plantar warts.\n      Patients with multiple plantar warts will be randomized to receive either pyruvic acid 70%\n      or compound salicylic acid solution (salicylic acid 16.7%, lactic acid 16.7%, and collodion\n      100%) applying topically twice a day for 4 weeks. Patients will be visited every 2 weeks for\n      one month after starting treatment and then every one month for up to 3 months. The number\n      and size of warts will be evaluated."
        }, 
        "brief_title": "Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Plantar Wart", 
        "condition_browse": {
            "mesh_term": [
                "Warts", 
                "Foot Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  aged 12 years and above\n\n          -  multiple warts (at least 2)\n\n        Exclusion Criteria:\n\n          -  mosaic warts\n\n          -  already under any treatment for warts\n\n          -  pregnant or lactating women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02151630", 
            "org_study_id": "393219"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pyruvic acid", 
                "intervention_name": "Pyruvic acid", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Salicylic acid", 
                "intervention_name": "Salicylic Acid", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Salicylic Acid", 
                "Salicylates"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "wart", 
            "verruca vulgaris", 
            "topical therapy", 
            "pyruvic acid", 
            "salicylic acid"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "contact": {
                "email": "dr.assafsaid@gmail.com", 
                "last_name": "Fatima Assaf, M.D.", 
                "phone": "0098 913 0965384"
            }, 
            "facility": {
                "address": {
                    "city": "Isfahan", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Skin Diseases and Leishmaniasis Research Center"
            }, 
            "investigator": {
                "last_name": "Fatima Assaf, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of 70% Pyruvic Acid Solution and Duofilm Solution in Treatment of Plantar Wart", 
        "overall_contact": {
            "email": "dr.assafsaid@gmail.com", 
            "last_name": "Fatima Assaf, M.D.", 
            "phone": "0098 913 0965384"
        }, 
        "overall_official": {
            "affiliation": "Isfahan University of Medical Sciences", 
            "last_name": "Fatima Assaf, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Patients will be visited every two weeks for one month and then every month for up to 3 months by a dermatologist. On each visit, warts will be inspected to determine the number of warts. Any wart totally non-detectable by inspection and touch will be considered as healed.", 
                "measure": "Wart number", 
                "safety_issue": "No", 
                "time_frame": "From before to 3 months after"
            }, 
            {
                "description": "Patients will be visited every two weeks for one month and then every month for up to 3 months by a dermatologist. On each visit, warts will be inspected to determine the size of warts. The size of the warts will be calculated as the mean size of all the warts.", 
                "measure": "Wart size", 
                "safety_issue": "No", 
                "time_frame": "From before to 3 months after"
            }
        ], 
        "reference": {
            "PMID": "21219294", 
            "citation": "Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol. 2011 Aug;165(2):233-46. doi: 10.1111/j.1365-2133.2011.10218.x. Epub 2011 May 26. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02151630"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Isfahan University of Medical Sciences", 
            "investigator_full_name": "Fatima Assaf", 
            "investigator_title": "Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Isfahan University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isfahan University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}